Human medicines European public assessment report (EPAR): Aldurazyme, laronidase, Date of authorisation: 09/06/2003, Revision: 27, Status: Authorised

Submitted by Anonymous (not verified) on 17 October 2024 - 14:46

Human medicines European public assessment report (EPAR): Aldurazyme, laronidase, Date of authorisation: 09/06/2003, Revision: 27, Status: Authorised

Determination of IgM antibodies to SARS-CoV-2 - Notified body 0123 - 03/02/2022 - View in the context of the performance evaluation consultation procedure (PECP)

Submitted by Anonymous (not verified) on 17 October 2024 - 13:20

Determination of IgM antibodies to SARS-CoV-2 - Notified body 0123 - 03/02/2022 - View in the context of the performance evaluation consultation procedure (PECP)

Submission of Manufacturers and Manufacturing Operations to Product Management Service (PMS), Online, European Medicines Agency, Amsterdam, the Netherlands, from 25 November 2024, 10:00 (CET) to 25 November 2024, 11:30 (CET)

Submitted by Anonymous (not verified) on 17 October 2024 - 10:53

Submission of Manufacturers and Manufacturing Operations to Product Management Service (PMS), Online, European Medicines Agency, Amsterdam, the Netherlands, from 25 November 2024, 10:00 (CET) to 25 November 2024, 11:30 (CET)

Human medicines European public assessment report (EPAR): Gefitinib Mylan, gefitinib, Date of authorisation: 27/09/2018, Revision: 7, Status: Withdrawn (authorisation)

Submitted by Anonymous (not verified) on 17 October 2024 - 10:28

Human medicines European public assessment report (EPAR): Gefitinib Mylan, gefitinib, Date of authorisation: 27/09/2018, Revision: 7, Status: Withdrawn (authorisation)

Q&A clinic on Product Management Service (PMS) Product User Interface (PUI) and Application Programming Interface (API) - 5 November 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 5 November 2024, 10:00 (CET) to 5 November 2024,

Submitted by Anonymous (not verified) on 17 October 2024 - 9:54

Q&A clinic on Product Management Service (PMS) Product User Interface (PUI) and Application Programming Interface (API) - 5 November 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 5 November 2024, 10:00 (CET) to 5 November 2024, 10:30 (CET)

Q&A Clinic on Product Management Service (PMS) Product UI & API (3), Online, European Medicines Agency, Amsterdam, the Netherlands, from 22 November 2024, 10:00 (CET) to 22 November 2024, 10:30 (CET)

Submitted by Anonymous (not verified) on 17 October 2024 - 9:39

Q&A Clinic on Product Management Service (PMS) Product UI & API (3), Online, European Medicines Agency, Amsterdam, the Netherlands, from 22 November 2024, 10:00 (CET) to 22 November 2024, 10:30 (CET)

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More